BARALDI, Pier Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 28.277
EU - Europa 8.903
AS - Asia 5.179
SA - Sud America 42
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 27
AF - Africa 23
Totale 42.481
Nazione #
US - Stati Uniti d'America 28.233
CN - Cina 3.127
DE - Germania 2.665
UA - Ucraina 2.238
TR - Turchia 1.691
GB - Regno Unito 955
IT - Italia 874
SE - Svezia 801
FI - Finlandia 483
RU - Federazione Russa 435
FR - Francia 156
VN - Vietnam 117
PL - Polonia 114
BE - Belgio 59
IN - India 47
HK - Hong Kong 36
KR - Corea 29
CA - Canada 28
JP - Giappone 27
EU - Europa 24
AU - Australia 23
IR - Iran 22
NL - Olanda 22
TW - Taiwan 19
CL - Cile 18
CZ - Repubblica Ceca 16
MX - Messico 16
IL - Israele 14
MA - Marocco 13
BR - Brasile 10
ID - Indonesia 10
RO - Romania 10
SG - Singapore 10
CO - Colombia 9
AT - Austria 8
CH - Svizzera 8
HU - Ungheria 8
IE - Irlanda 7
MY - Malesia 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
ES - Italia 6
PK - Pakistan 6
ZA - Sudafrica 6
PT - Portogallo 5
BG - Bulgaria 4
GR - Grecia 4
IQ - Iraq 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
BD - Bangladesh 3
EG - Egitto 3
HR - Croazia 3
LT - Lituania 3
MD - Moldavia 3
DK - Danimarca 2
LU - Lussemburgo 2
PS - Palestinian Territory 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
EC - Ecuador 1
IM - Isola di Man 1
KH - Cambogia 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
MN - Mongolia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 42.481
Città #
Woodbridge 3.792
Fairfield 3.594
Jacksonville 2.451
Houston 2.445
Chandler 2.077
Ashburn 2.032
Ann Arbor 1.914
Seattle 1.499
Wilmington 1.382
Cambridge 1.093
Izmir 799
Nanjing 771
Beijing 541
Princeton 512
Boardman 399
San Diego 322
Shenyang 266
Ferrara 261
Nanchang 213
Milan 188
Shanghai 182
Hebei 158
New York 154
San Mateo 154
Bremen 144
Addison 142
Tianjin 141
Changsha 139
Jiaxing 122
Dearborn 114
Dong Ket 114
Jinan 106
Warsaw 104
Philadelphia 88
Falls Church 86
Norwalk 83
Redwood City 78
Kunming 76
Zhengzhou 70
Mountain View 59
Brussels 58
London 57
Ningbo 50
Auburn Hills 47
Orange 47
Verona 43
Guangzhou 42
Los Angeles 39
Des Moines 37
Indiana 37
Munich 35
Taizhou 34
Lanzhou 32
Hong Kong 28
Tappahannock 28
Hangzhou 27
Chicago 26
Paris 25
Washington 25
Helsinki 24
Düsseldorf 22
Mcallen 22
Redmond 22
Augusta 20
Haikou 20
Montréal 20
Taipei 19
Duncan 15
Leawood 15
Hefei 14
Kilburn 14
San Francisco 14
Xian 13
Bari 12
Monmouth Junction 12
Fuzhou 11
Yellow Springs 11
Ardabil 10
Chiswick 9
Corvallis 9
Marrakesh 9
Olomouc 9
Rome 9
Taiyuan 9
Weihai 9
Padova 8
Palo Alto 8
Bologna 7
Changchun 7
Dublin 7
Prescot 7
Acton 6
Budapest 6
Hounslow 6
Medellín 6
Moscow 6
Mumbai 6
New Bedfont 6
Oslo 6
Pune 6
Totale 30.053
Nome #
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 353
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 293
1,4-Diketones via Isoxazole Intermediates 283
1,2,3-triazolo[5,4-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: A new class of A(2A) adenosine receptor antagonists 251
null 227
A glance at adenosine receptors: Novel target for antitumor therapy 191
1-methyl-3-nitro-5-methoxycarbonyl pyrazole 161
The A3 adenosine receptor: history and perspectives 159
A new, efficient synthesis of muscimol (5-ammoniomethylisoxazol-3-olate). 152
A synthetic approach for the preparation of rigid analogs of 1,3-dipropyl-7-methyl-8-aryl/heteroarylstyryl xanthines 149
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 149
Synthesis and biological effects of a new series of 2-amino-3-benzoylthiophenes as allosteric enhancers of A1-adenosine receptor 148
Azaprostaglandin Analogues. Synthesis and Biological Properties of 11-Azaprostaglandin Derivatives 147
A facile, efficient synthesis of 2-substituted-4-hydroxy-2-cyclopenten-1-ones 147
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 145
Adenosine Receptor Antagonists: Translating Medicinal Chemistry and Pharmacology into Clinical Utility 144
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 143
Geiparvarin analogs. 2. Synthesis and cytostatic activity of 5-(4-arylbutadienyl)-3(2H)-furanones and of N-substituted 3-(4-oxo-2-furanyl)-2-buten-2-yl carbamates. 142
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 140
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 140
Methyl 4-oxothiolane-3-carboxylate and methyl 2-methyl-4-oxothiolane-3- carboxylate anions as synthetic equivalents of α-acrylate and α-crotonate anions. Formal synthesis of integerrinecic acid 139
Geiparvarin Analogs. 3. Synthesis and cytostatic activity of 3(2H)-furanone and 4,5-dihydro-3(2H)-furanone congeners of geiparvarin, containing a geraniol-like fragment in the side chain 139
3,5-Disubstituted isoxazoles as a latent aldol moiety: application to the synthesis of (±)-[6]-gingerol. 139
Design, Synthesis, DNA Binding, and Biological Evaluation of Water-Soluble Hybrid Molecules Containing Two Pyrazole Analogues of the Alkylating Cyclopropylpyrroloindole (CPI) Subunit of the Antitumor Agent CC-1065 and Polypyrrole Minor Groove Binders. 139
Active γ-manganese dioxide promoted conversion of 4,5-dihydro-1,2-oxazoles to 1,2-oxazoles. 139
Novel iodoacetamido benzoheterocyclic derivatives with potent antileukemic activity are inhibitors of STAT5 phosphorylation 139
Ethyl 2,4-dioxoalkanoates as starting materials for a convenient route to 3(2H)-furanones and 3(2H)-furanimines 138
Synthesis and biological evaluation of 2-and 3-aminobenzo[b]thiophene derivatives as antimitotic agents and inhibitors of tubulin polymerization 137
Design, synthesis, in vitro, and in vivo anticancer and antiangiogenic activity of novel 3-arylaminobenzofuran derivatives targeting the colchicine site on tubulin 137
Blockade of A2A receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata 136
Current status of A1 adenosine receptor allosteric enhancers 136
A [3+2] nitrile oxide intermolecular cycloaddition approach to 4,5-dihydro-3(2H)-furanone and 3(2H)-furanone ring systems: application to the formal synthesis of (±)-ascofuranone and geiparvarin. 136
Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents 136
Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles 135
Geiparvarin Analogs. 4.1. Synthesis and Cytostatic Activity of Geiparvarin Analogs Bearing a Carbamate Moiety or a Furocoumarin Fragment on the Alkenyl Side Chain 134
Design, synthesis and in vitro cytotoxicity of a cis-dichloroplatinum(II) complex linked to the minor groove binder stallimycin 134
Adenosine receptors and human melanoma 134
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo[2,1-c][1,4] benzodiazepine and minor-groove-binding oligopyrrole carriers 134
3,5-Disubstituted isoxazoles as synthons for (±)-pyrenophorin and (±)-vermiculine synthesis. 133
2-Arylamino-4-Amino-5-Aroylthiazoles. "One-Pot" Synthesis and Biological Evaluation of a New Class of Inhibitors of Tubulin Polymerization. 133
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 133
Design, synthesis and growth inhibition activity of bis-epoxyethyl derivatives of stallimycin modified on the amidino moiety 132
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 132
A formal total synthesis (±)-forskolin through [3+2] nitrile oxide cycloaddition chemistry 132
DNA minor groove binders as potential antitumor and antimicrobial agents 131
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 131
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 131
Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3 ',4 ',5 '-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents 130
Design, synthesis and antiproliferative activity of novel heterobivalent hybrids based on imidazo[2,1-b][1,3,4]thiadiazole and imidazo[2,1-b][1,3]thiazole scaffolds 130
Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3’,4’,5’-Trimethoxyphenyl)-2-Aryl-1H-Imidazole 130
Synthesis of a new series of pyrazolo[1,5-a]pyrimidines structurally related to zaleplon 129
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 129
A [3 + 2] nitrile oxide cycloaddition approach to retinoids 128
Synthesis of conformationally constrained analogues of KN62, a potent antagonist of the P2X7-receptor 128
Synthesis of hybrid distamycin-cysteine labeled with 99mTc: a model for a novel class of cancer imaging agents 128
A convenient synthesis of unsymmetrically substituted terphenyls of biologically active stilbenes via a double Suzuki cross-coupling protocol 128
From tyrosine to glycine: Synthesis and biological activity of potent antagonists of the purinergic P2X(7) receptor 127
Hybrid molecules based on distamycin A as potential antitumor agents 127
Synthesis of 2-(5-substituted isoxazol-3-yl)-4-oxo-3-thiazolidinyl alkanoic acids 126
2,3a,5,6,7,7a-Hexahydro-3H,4H-benzothiophene-3,4-dione and cyclopenta[b]tetrahydrothiophene-3,4-dione enolate anions as synthetic equivalents to cyclohex-2-enone and cyclopent-2-enone C-2-carbanions. 126
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 126
Novel 8-heterocyclyl xanthine derivatives in drug development - An update 126
Allosteric modulators for the A1-adenosine receptor 124
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 124
1H-pyrazolo[2,3-d][1,2,4]triazine-3,7-diones as a new class of human leukocyte elastase inhibitors 123
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 123
Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents 123
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 123
Total synthesis of (±)-isoclovene. 122
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 122
A new direct glycosylation of pyrimidine, pyrazole, imidazole and purine heterocycles via their N-tetrahydropyranyl (THP) derivatives 122
Synthesis of syn- and anti-tricyclo[4.1.0.02,4]heptan-5-ones and related compounds. 121
A new nitrile oxide based synthesis of the antitumor agent geiparvarin 121
Synthesis and biological evaluation of 2-(3 ',4 ',5 '-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitors 121
null 121
Pyrazolo [4,3-e][1,2,4]triazolo[1,5-c]pyrimidine template: Organic and medicinal chemistry approach 121
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxyphenylsulfonyl)-5-aryl thiophenes as a new class of antitubulin agents 121
null 121
Synthesis of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine and 1,2,3-triazolo[4,5-e]1,2,4-triazolo[1,5-c]pyrimidine displaying potent and selective activity as A2a adenosine receptor antagonists 120
Synthesis and antitumor activity of novel distamycin derivatives 120
Recent improvements in the development of A2B adenosine receptor agonists. 120
null 120
Synthesis of 6‐substituted‐4,5‐dihydro‐3(2H)‐pyridazinones 119
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 119
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D 1 or D2 dopamine receptor agonists 119
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 119
Synthesis and cytotoxic activity of 6-vinyl- and 6-ethynyluridine and 8-vinyl- and 8-ethynyladenosine 118
null 118
A3 adenosine receptor antagonists: History and future perspectives 118
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 118
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 117
Preparation of 3,4-dihydroxy-1-benzeneethanol: a reinvestigation 116
Pyrazole-Related Nucleosides. Synthesis and Antiviral/Antitumor Activity of Some Substituted Pyrazole and Pyrazolo[4,3-d]-1,2,3-triazin-4-one Nucleosides 116
Stereospecific nitromethane conjugate addition to 4-oxygenated 2-substituted cyclopent-2-enones: a simple approach to prostaglandins. 115
N-arylpiperazine modified analogues of the P2X(7) receptor KN-62 antagonist are potent inducers of apoptosis of human primary osteoclasts 115
Involvement of globus pallidus in the antiparkinsonian effects of adenosine A2A receptor antagonists. 115
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 115
A new simple synthesis of a-substituted acrylonitriles 115
Allosteric Modulators of the A1 Adenosine receptor 115
Bis-epoxyethyl derivatives of distamycin A modified on the amidino moiety: Induction of production of fetal hemoglobin in human erythroid precursor cells 115
Totale 13.766
Categoria #
all - tutte 149.575
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.456
Totale 151.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.179 0 0 0 0 0 0 0 0 0 0 0 2.179
2019/20208.848 1.601 282 278 1.280 575 1.001 704 875 643 1.046 409 154
2020/20216.321 641 592 270 697 298 649 146 728 122 786 837 555
2021/20225.107 159 470 374 291 374 252 208 244 198 362 528 1.647
2022/20234.812 509 249 108 647 884 775 145 392 614 31 286 172
2023/20241.968 243 309 129 82 170 287 95 398 28 60 56 111
Totale 42.951